Sales rise 30.25% to Rs 30.70 crore
Net profit of Kilitch Drugs (India) rose 12.50% to Rs 2.43 crore in the quarter ended September 2022 as against Rs 2.16 crore during the previous quarter ended September 2021. Sales rose 30.25% to Rs 30.70 crore in the quarter ended September 2022 as against Rs 23.57 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales30.7023.57 30 OPM %12.8715.53 -PBDT2.443.70 -34 PBT1.553.00 -48 NP2.432.16 13Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
